https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-07-19 / Int J Mol Sci 2020 Jul;21(14)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-07-19 / Int J Mol Sci 2020 Jul;21(14)2020-07-19 00:00:002020-07-19 00:00:00Modulated Electro-Hyperthermia Resolves Radioresistance of Panc1 Pancreas Adenocarcinoma and Promotes DNA Damage and Apoptosis In Vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-07-01 / Int J Hyperthermia 2020 07;37(2):3-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-07-01 / Int J Hyperthermia 2020 07;37(2):3-192020-07-01 00:00:002020-07-01 00:00:00Hyperthermia treatment advances for brain tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-06-30 / Expert Rev Anticancer Ther 2020 Aug;20(8):639-646
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-06-30 / Expert Rev Anticancer Ther 2020 Aug;20(8):639-6462020-06-30 00:00:002021-11-15 13:19:48Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-06-12 / Front Oncol 2020;10:819
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-06-12 / Front Oncol 2020;10:8192020-06-12 00:00:002020-06-12 00:00:00Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-06-02 / Sci Rep 2020 Jun;10(1):8936
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-06-02 / Sci Rep 2020 Jun;10(1):89362020-06-02 00:00:002020-06-02 00:00:00Relationship between Energy Dosage and Apoptotic Cell Death by Modulated Electro-Hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-05-19 / Medicines (Basel) 2020 May;7(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-05-19 / Medicines (Basel) 2020 May;7(5)2020-05-19 00:00:002021-11-15 20:10:42Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-05-08 / J Therm Biol 2020 Jul;91:102615
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-05-08 / J Therm Biol 2020 Jul;91:1026152020-05-08 00:00:002020-05-08 00:00:00Hyperthermia and protein homeostasis: Cytoprotection and cell death
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-04-02 / Adv Drug Deliv Rev 2020;163-164:145-156
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-04-02 / Adv Drug Deliv Rev 2020;163-164:145-1562020-04-02 00:00:002020-04-02 00:00:00A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-24 / Front Oncol 2020;10:376
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-24 / Front Oncol 2020;10:3762020-03-24 00:00:002020-12-07 11:23:38Potentiation of the Abscopal Effect by Modulated Electro-Hyperthermia in Locally Advanced Cervical Cancer Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-17 / J Adv Res 2020 Jul;24:175-182
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-17 / J Adv Res 2020 Jul;24:175-1822020-03-17 00:00:002023-01-31 16:04:06A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer
